As of 2024-12-14, the Intrinsic Value of ADMA Biologics Inc (ADMA) is
7.10 USD. This ADMA valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 18.59 USD, the upside of ADMA Biologics Inc is
-61.80%.
The range of the Intrinsic Value is 6.06 - 8.02 USD
ADMA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(51.46) - (8.28) |
(13.89) |
-174.7% |
| DCF (Growth 10y) |
(3.27) - (10.25) |
(4.22) |
-122.7% |
| DCF (EBITDA 5y) |
6.06 - 8.02 |
7.10 |
-61.8% |
| DCF (EBITDA 10y) |
17.07 - 24.95 |
20.97 |
12.8% |
| Fair Value |
2.32 - 2.32 |
2.32 |
-87.51% |
| P/E |
5.59 - 17.24 |
11.99 |
-35.5% |
| EV/EBITDA |
1.51 - 8.67 |
4.87 |
-73.8% |
| EPV |
(1.55) - (2.17) |
(1.86) |
-110.0% |
| DDM - Stable |
3.91 - 30.64 |
17.28 |
-7.1% |
| DDM - Multi |
0.60 - 3.68 |
1.04 |
-94.4% |
ADMA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
4,394.49 |
| Beta |
2.03 |
| Outstanding shares (mil) |
236.39 |
| Enterprise Value (mil) |
4,409.11 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.00% |
| Cost of Debt |
8.73% |
| WACC |
6.98% |